跳至主要内容
临床试验/ITMCTR2024000124
ITMCTR2024000124尚未招募2 期

Real World Study of Yiqifumai Prescription in Treating Heart Failure

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 85(—)
性别
All

入选标准

  • Meet the diagnostic criteria for heart failure;
  • Age =18 years old, gender unlimited;
  • NYHA cardiac function Grade II to IV

排除标准

  • 1.Complicated with acute myocardial infarction (within 2 months), constrictive pericarditis, acute cerebrovascular accident, acute myocarditis, cardiogenic shock, congenital heart disease, primary severe valvular disease, symptomatic hypotension, severe arrhythmia and hemodynamic changes;
  • 2.There are serious endocrine diseases such as malignant tumor, severe hepatic and renal insufficiency, primary disease of blood system, or diabetes with serious complications, hyperthyroidism, etc.

研究者

相似试验